Manica Isiguzo
Pulmonary Disease · Beachwood, OHNPI 1932158078
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,580 of the $58,301 with a category attached, or 61.0%. 32 manufacturers reported payments, led by Boehringer Ingelheim at 48.6% of the total. Reporting peaked in 2020 at $21,113 and has fallen 98.8% since, to $249 in 2025. Among pulmonary disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 582 payments — averaging $100.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$28K
- Genentech USA, Inc.$15K
- Actelion Pharmaceuticals US, Inc.$5K
- Bayer$3K
- GSK$2K
- AstraZeneca$1K
- plus $4K from 26 others
What the payments were for
- Consulting fees$7,74513%
- Speaking & faculty fees$35,58061%
- Travel & lodging$4,2367%
- Food & beverage$10,67718%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 86 | $28,338 |
| Genentech USA, Inc. | 24 | $15,477 |
| Actelion Pharmaceuticals US, Inc. | 111 | $4,851 |
| Bayer | 5 | $3,274 |
| GSK | 125 | $1,571 |
| AstraZeneca(2 entities) | 62 | $1,058 |
| Mylan Specialty L.p. | 40 | $699 |
| United Therapeutics Corporation | 25 | $463 |
| Regeneron Healthcare Solutions, Inc. | 12 | $354 |
| Grifols USA, LLC | 14 | $329 |
| Intuitive Surgical | 2 | $249 |
| Sanofi | 10 | $211 |
| Philips North America LLC | 8 | $147 |
| Abiomed | 1 | $147 |
| Novartis | 8 | $144 |
| Gilead | 8 | $124 |
| Sandoz | 6 | $117 |
| Johnson & Johnson | 3 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Advanced Respiratory, Inc | 5 | $87 |
| Merck | 5 | $86 |
| Baxter Healthcare | 3 | $57 |
| Circassia Inc. | 3 | $51 |
| CSL Behring | 1 | $42 |
| Portola Pharmaceuticals, LLC | 2 | $37 |
| Insmed, Inc. | 2 | $34 |
| Pulmonx Corporation | 1 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Cvrx, Inc. | 1 | $23 |
| Amgen | 1 | $18 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$58,301 in reported general payments places this provider in the 90th percentile of 571 pulmonary disease providers in Ohio.
Other pulmonary disease in Beachwood
- Joseph KhabbazaAkron$655K
- Robert BaughmanCincinnati$640K
- Kristin HighlandCleveland$551K
- Bruce CorserCincinnati$502K
- Jason StieneckerLima$397K
- Mohammad SheattCincinnati$389K
- Mohammad KhanAkron$388K
- Thomas YungerDayton$353K
- Joseph CiceniaCleveland$350K
- Jean ElwingCincinnati$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.